Get our newsletter delivered directly to your inbox
I have already subscribed | Do not show this message again
Boletines
Your email has been successfully registered.
The antigen test can identify the virus in four hours. The firsts 644 kits were sent to the Medicines Marketing and Distribution Company (EMCOMED) for mass-scale production and distribution.
Cuban President Miguel Díaz-Canel announced that the UMELISA SARS-CoV-2 antigen diagnostic system aims to reinforce the country's response to the COVID-19 pandemic amid a surge in cases.
"Another achievement of Cuban science. Umelisa SARS-COV-2 antigen, a 100% Cuban diagnostic system," the president said via Twitter.
Otro logro de la ciencia cubana. Umelisa SARS-COV-2 antígeno, un sistema de diagnóstico 100 % cubano #CubaVivahttps://t.co/rO6S0ry1MT
— Miguel Díaz-Canel Bermúdez (@DiazCanelB)
July 5, 2021
"Another achievement of Cuban science. Umelisa SARS-COV-2 antigen, a 100% Cuban diagnostic system."
The antigen test can identify the virus in four hours. The firsts 644 kits were sent to the Medicines Marketing and Distribution Company (EMCOMED) for mass-scale production and distribution.
The authorities expect to deliver more than 1,600 UMELISA diagnostic systems by July 15 and provide the health system with 705,000 kits.